ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Ten-year migration analysis of a cementless metaphyseal-anchored short femoral stem in total hip arthroplasty.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeShort-stem total hip arthroplasty aims to improve metaphyseal load transfer while enabling minimally invasive implantation via the direct anterior approach. Long-term migration and clinical data for these implants remain limited. This study evaluated 10-year femoral stem migration, periprosthetic radiolucency, and clinical outcomes for a cementless, metaphyseal-anchored short stem.
methodsIn this single-center retrospective study, 66 hips in 57 patients underwent primary THA with the AMIStem-H (Medacta International) between 2010 and 2012. Stem subsidence was measured serially using EBRA-FCA, radiolucency was graded by Gruen zone, and clinical function was assessed with the Harris Hip Score (HHS).
resultsMedian stem subsidence increased from 0.51 mm at 3 months to 1.45 mm (IQR 0.72-2.12 mm) at 10 years, with most migration occurring in the first five years; 33.3% of stems subsided > 2 mm. Radiolucency > 2 mm was present in 33.3% of hips, without progression between 5 and 10 years or correlation with clinical outcome. Median HHS at final follow-up was 97, with 89.2% of hips rated good or excellent. Two implants (one stem, one acetabular component) required revision for aseptic loosening.
conclusionThe AMIStem-H demonstrated durable fixation and excellent clinical outcomes at 10 years, with limited, predominantly early axial migration; neither subsidence nor periprosthetic radiolucency was associated with functional outcome. As many patients who received an AMIStem-H are now entering long-term follow-up, surveillance should prioritize new symptoms or progressive radiographic change over isolated, low-magnitude subsidence.
Indexed as
Identifiers
42663680What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.